FDA clears cardiogenic shock monitor

- A new FDA-cleared software system continuously monitors cardiogenic shock patients using an established shock classification framework. - The system provides real-time data mapped to the Society for Cardiovascular Angiography and Interventions (SCAI) classification. - This narrow surveillance tool is designed to sharpen trend recognition for deterioration, making it easier to integrate continuous monitoring into acute-care workflows (medscape.com).